Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Phreesia, Inc. is a healthcare technology company that provides a cloud-based SaaS platform designed to modernize the patient intake, access, and engagement experience for healthcare providers. The company operates within the healthcare information technology and digital health services industries, focusing on administrative workflow automation, patient data collection, and communication tools that integrate with electronic health record systems. Phreesia primarily serves healthcare provider organizations, including physician practices, health systems, and specialty clinics, as well as life sciences companies seeking compliant patient engagement and education channels.
The company’s core revenue drivers include subscription-based software fees from provider customers and advertising and engagement services sold to life sciences companies. Phreesia is positioned as a leader in digitizing the point-of-care experience, with a platform that spans pre-visit, in-clinic, and post-visit interactions. Founded in 2005, Phreesia initially focused on electronic registration and gradually expanded into broader patient engagement, data analytics, and life sciences media offerings, culminating in its initial public offering in 2019 and subsequent expansion through acquisitions.
Business Operations
Phreesia operates through two primary business segments: Provider Solutions and Life Sciences Solutions. The Provider Solutions segment generates the majority of revenue through recurring SaaS subscriptions that enable patient registration, scheduling, payments, clinical intake, and communication workflows across web, mobile, and in-clinic devices. The Life Sciences Solutions segment monetizes Phreesia’s network by offering pharmaceutical and medical device companies targeted digital education, clinical trial awareness, and engagement programs delivered at the point of care.
Operations are primarily based in the United States, with technology infrastructure hosted on secure cloud environments and integrated with major EHR platforms. Phreesia controls its proprietary software platform, patient engagement interfaces, and data analytics capabilities. The company has expanded its offerings through subsidiaries and acquired platforms, including MediFind, PatientKeeper, and Insignia Health, which contribute capabilities in clinical decision support, physician workflow tools, and patient activation methodologies.
Strategic Position & Investments
Phreesia’s strategic direction centers on deepening its role as an end-to-end patient access and engagement platform while expanding monetization opportunities within its provider network. Growth initiatives include increasing penetration within large health systems, expanding specialty-specific solutions, and enhancing data-driven personalization for both providers and life sciences clients. The company has pursued growth through targeted acquisitions that add complementary technology and clinical engagement capabilities.
Notable investments include the acquisitions of PatientKeeper to extend clinician workflow tools, MediFind to enhance condition-specific patient matching and education, and Insignia Health to integrate evidence-based patient activation and behavioral science methodologies. Phreesia is also investing in analytics, interoperability, and scalable engagement formats to align with evolving regulatory requirements and value-based care models. Data on certain emerging technology initiatives remains inconclusive based on available public sources.
Geographic Footprint
Phreesia is headquartered in the United States, with its principal executive offices in New York, New York. The company’s operations and revenue are predominantly derived from the U.S. healthcare market, where it serves thousands of provider organizations across multiple specialties and care settings. Its platform is designed to support national-scale healthcare systems and geographically distributed practices.
While international operations are limited, Phreesia has some exposure to Canada through acquired technologies and customer relationships. Overall, the company’s strategic and operational influence remains concentrated in North America, with no material revenue contribution from other continents disclosed in public filings.
Leadership & Governance
Phreesia was founded by Chaim Indig, who has played a central role in shaping the company’s mission to humanize healthcare through technology. The leadership team emphasizes a strategy focused on long-term customer relationships, recurring revenue growth, and disciplined investment in scalable healthcare infrastructure. Governance is overseen by a board with experience in healthcare, technology, and public company operations.
Key executives include:
- Chaim Indig – Chief Executive Officer and Co-Founder
- Randy Rasmussen – Chief Financial Officer
- David Linetsky – Chief Technology Officer
- Emily J. Green – Chief Operating Officer
- Megan Cole – Chief Legal and Administrative Officer